000403 派林生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产319-4.20%33336200
固定资产1,066,89713.14%942,994873,673739,736350,240
在建工程670,46415.06%582,700385,735334,37632,732
无形资产208,912-1.73%212,593192,516200,05265,460
商誉2,614,6120.00%2,614,6122,614,6122,614,6120
其他非流动资产855,8040.54%851,167868,452729,696358,583
5,417,0084.09%5,204,3994,935,3494,618,471807,014

流动资产
货币资金850,349-40.51%1,429,3501,000,797885,673102,827
应收账款513,513-12.01%583,579835,877535,379277,491
存货1,139,64025.32%909,375623,689738,968441,761
其他流动资产916,16781.86%503,771586,612309,30750,634
3,419,669-0.19%3,426,0753,046,9762,469,327872,713

流动负债
短期借款249,161-0.56%250,571275,102113,519332,406
应付票据0--0000
应付帐款227,29547.26%154,347158,370170,76145,487
其他流动负债443,718-14.22%517,276525,837358,009267,621
920,174-0.22%922,195959,309642,289645,514
流动资产净值2,499,495-0.18%2,503,8802,087,6671,827,038227,199
资产总额减流动负债7,916,5032.70%7,708,2807,023,0166,445,5091,034,214

非流动负债
长期借款222,54513.50%196,07952,886020,022
应付债券0--0000
其他非流动负债84,905-6.01%90,337109,002117,77947,285
307,4507.34%286,416161,888117,77967,307

总权益
    实收股本733,0430.01%733,001732,387732,919492,435
    储备项目6,882,9282.80%6,695,6496,135,1375,592,745472,881
股东权益7,615,9712.52%7,428,6496,867,5246,325,664965,316
非控股权益(6,918)1.96%(6,785)(6,397)2,0661,590